SIGA Technologies Newswire

SIGA Technologies Newswire

Comprehensive Real-Time News Feed for SIGA Technologies.

Results 1 - 20 of 72 in SIGA Technologies

  1. SIGA Technologies Announces FDA Accepts NDA and Grants Priority...Read the original story w/Photo

    Feb 6, 2018 | Drugs.com

    SIGA Technologies, Inc. , a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that the U.S. Food and Drug Administration has accepted the company's New Drug Application for its oral formulation of TPOXX . TPOXX is a novel small molecule antiviral therapy for smallpox infection.

    Comment?

  2. Reviewing SIGA TechnologiesRead the original story w/Photo

    Feb 27, 2018 | Daily Political

    SIGA Technologies and ContraFect are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, profitability, analyst recommendations, institutional ownership, valuation and dividends. 6.7% of SIGA Technologies shares are owned by institutional investors.

    Comment?

  3. Chimerix - Years Behind The CompetitionRead the original story w/Photo

    Feb 8, 2018 | Seeking Alpha

    ... event: Cidofovir, marketed by Gildead ( GILD ) and Pfizer ( PFE )) and Tecovirimat which is marketed by SIGA Technologies ( SIGA ). Cidofovir acts as a metabolite inhibitor - preventing viral replication - but has a high kidney toxicity and must be ...

    Comment?

  4. SIGA Technologies Announces FDA Accepts NDA and Grants Priority...Read the original story

    Feb 7, 2018 | Information Technology

    SIGA Technologies, Inc. , a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that the U.S. Food and Drug Administration has accepted the company's New Drug Application for its oral formulation of TPOXX . TPOXX is a novel small molecule antiviral therapy for smallpox infection.

    Comment?

  5. Atletico Pantoja boots out W Connection from club championshipRead the original story w/Photo

    Feb 5, 2018 | Trinidad Guardian

    W Connection's Alvin Jones attempts to dispossess Club Atletico Pantoja's Yefferson Moreira during their Flow Caribbean Football Club Championship encounter at the Ato Boldon Stadium, Couva, on Sunday night. Pantoja won 3-0.

    Comment?

  6. Comparing SIGA TechnologiesRead the original story w/Photo

    Jan 30, 2018 | IntersportsWire

    SIGA Technologies and Sevion Therapeutics are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk. Sevion Therapeutics has lower revenue, but higher earnings than SIGA Technologies.

    Comment?

  7. Head-To-Head Analysis: SIGA TechnologiesRead the original story w/Photo

    Jan 25, 2018 | AmericanBankingNews.com

    SIGA Technologies and Sevion Therapeutics are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. SIGA Technologies has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500.

    Comment?

  8. Critical Comparison: SIGA TechnologiesRead the original story w/Photo

    Jan 25, 2018 | The Breeze

    SIGA Technologies and VBI Vaccines are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk. This is a breakdown of current ratings and recommmendations for SIGA Technologies and VBI Vaccines, as provided by MarketBeat.com.

    Comment?

  9. Financial Contrast: Trillium TherapeuticsRead the original story w/Photo

    Jan 14, 2018 | IntersportsWire

    Trillium Therapeutics and SIGA Technologies are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Trillium Therapeutics has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500.

    Comment?

  10. Trillium Therapeutics (TRIL) & SIGA Technologies (SIGA) Head-To-Head ContrastRead the original story w/Photo

    Jan 9, 2018 | Daily Political

    Trillium Therapeutics and SIGA Technologies are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Trillium Therapeutics has higher earnings, but lower revenue than SIGA Technologies.

    Comment?

  11. Contrasting Trillium TherapeuticsRead the original story w/Photo

    Jan 9, 2018 | AmericanBankingNews.com

    Trillium Therapeutics and SIGA Technologies are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, profitability, analyst recommendations and earnings. This is a summary of recent ratings and target prices for Trillium Therapeutics and SIGA Technologies, as provided by MarketBeat.com.

    Comment?

  12. SIGA Technologies (SIGA) and Trillium Therapeutics (TRIL) Head to Head AnalysisRead the original story w/Photo

    Jan 8, 2018 | IntersportsWire

    SIGA Technologies and Trillium Therapeutics are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations. 6.7% of SIGA Technologies shares are held by institutional investors.

    Comment?

  13. Trillium Therapeutics (TRIL) & SIGA Technologies (SIGA) Head-To-Head AnalysisRead the original story w/Photo

    Jan 6, 2018 | AmericanBankingNews.com

    Trillium Therapeutics and SIGA Technologies are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Trillium Therapeutics has a beta of 1.78, suggesting that its share price is 78% more volatile than the S&P 500.

    Comment?

  14. Head to Head Analysis: Aevi Genomic MedicineRead the original story w/Photo

    Jan 5, 2018 | AmericanBankingNews.com

    Aevi Genomic Medicine and SIGA Technologies are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk and valuation. 16.8% of Aevi Genomic Medicine shares are held by institutional investors.

    Comment?

  15. Global Poxviridae Infections Drug Market by Manufacturers, Types,...Read the original story

    Jan 5, 2018 | Emailwire.com

    ... Inc., China Biologic Products, Inc., CJ HealthCare Corp., EpiVax, Inc., N & N Pharmaceuticals Inc., SIGA Technologies, Inc., Takeda Pharmaceutical Company Limited, Tonix Pharmaceuticals Holding Corp., Verrica Pharmaceuticals Inc. and others. ...

    Comment?

  16. Comparing SIGA TechnologiesRead the original story w/Photo

    Jan 4, 2018 | AmericanBankingNews.com

    SIGA Technologies and Mirati Therapeutics are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership. 6.7% of SIGA Technologies shares are held by institutional investors.

    Comment?

  17. Comparing SIGA TechnologiesRead the original story w/Photo

    Jan 3, 2018 | The Breeze

    SIGA Technologies and VBI Vaccines are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. 6.7% of SIGA Technologies shares are held by institutional investors.

    Comment?

  18. Comparing VBI VaccinesRead the original story w/Photo

    Jan 1, 2018 | IntersportsWire

    SIGA Technologies and VBI Vaccines are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. This is a breakdown of recent ratings and price targets for SIGA Technologies and VBI Vaccines, as provided by MarketBeat.com.

    Comment?

  19. Critical Contrast: SIGA TechnologiesRead the original story w/Photo

    Dec 28, 2017 | IntersportsWire

    SIGA Technologies and Soligenix are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends and profitability. SIGA Technologies has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.

    Comment?

  20. Reviewing Osiris TherapeuticsRead the original story w/Photo

    Dec 28, 2017 | The Breeze

    Osiris Therapeutics and SIGA Technologies are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Osiris Therapeutics has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.

    Comment?